Zobrazeno 1 - 10
of 745
pro vyhledávání: '"Hyun-Cheol Chung"'
Autor:
Ulrich T. Hacker, Dirk Hasenclever, Nicolas Linder, Gertraud Stocker, Hyun‐Cheol Chung, Yoon‐Koo Kang, Markus Moehler, Harald Busse, Florian Lordick
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 11, Iss 1, Pp 135-144 (2020)
Abstract Background Body fat and/or muscle composition influences prognosis in several cancer types. For advanced gastric and gastroesophageal junction cancer, we investigated which body composition parameters carry prognostic information beyond well
Externí odkaz:
https://doaj.org/article/2022d846a371467cbc1247d80ce6e73f
Autor:
Juin Park, Sun Kyoung Kang, Woo Sun Kwon, Inhye Jeong, Tae Soo Kim, Seo Young Yu, Sang Woo Cho, Hyun Cheol Chung, Sun Young Rha
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-11 (2023)
Abstract Trastuzumab is used to treat HER2-amplified metastatic gastric cancer; however, most patients become trastuzumab-resistant within a year. Knowledge of the mechanisms underlying trastuzumab resistance is required to overcome this limitation.
Externí odkaz:
https://doaj.org/article/9c8ac4ba3ae74cd38342c478ae5a2715
Autor:
Si Won Lee, Jung Hye Kwon, Seung-hoon Beom, Sang Joon Shin, Hyo Song Kim, Sun Young Rha, Minkyu Jung, Joo Hyuk Sohn, Joong-Bae Ahn, Hyun Cheol Chung, Gun Min Kim, Hye Ryun Kim, Beodeul Kang, Youn Jung Hu, Hye Jin Choi
Publikováno v:
Palliative Medicine Reports, Vol 4, Iss 1, Pp 9-16 (2023)
Background: The acute palliative care unit (APCU) bridges between active cancer treatment and hospice care. However, no study has proven the efficacy of APCU in Korea. Objective: To evaluate the first-year outcomes of the patients admitted to an APCU
Externí odkaz:
https://doaj.org/article/6e04cc2ec19141fb935e1f00818277e8
Autor:
Choong-kun Lee, Sun Young Rha, Hyo Song Kim, Minkyu Jung, Beodeul Kang, Jingmin Che, Woo Sun Kwon, Sejung Park, Woo Kyun Bae, Dong-Hoe Koo, Su-Jin Shin, Hyunki Kim, Hei-Cheul Jeung, Dae Young Zang, Sang Kil Lee, Chung Mo Nam, Hyun Cheol Chung
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-12 (2022)
In patients with advanced gastric cancer (AGC), resistance to treatment with trastuzumab and cytotoxic chemotherapy remains high. Here, the authors report the results of a phase Ib/II clinical trial assessing the safety and clinical response to a qua
Externí odkaz:
https://doaj.org/article/d65078acd4ba4fb29a71cb5da63dbffa
Autor:
Kohei Shitara, Kei Muro, Razvan Cristescu, Michael Nebozhyn, Andrey Loboda, Hyun Cheol Chung, Wasat Mansoor, Mustafa Ozguroglu, Mario Mandala, Maria Di Bartolomeo, Christian Caglevic, Julie Kobie, Min-Hee Ryu, Z Alexander Cao, Tomasz Olesinski, Eray Goekkurt, Raymond S McDermott, Zev A Wainberg, Chie-Schin Shih
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 6 (2023)
Background In the randomized, controlled, phase III KEYNOTE-061 trial, second-line pembrolizumab did not significantly prolong overall survival (OS) versus paclitaxel in patients with PD-L1-positive (combined positive score ≥1) advanced gastric/gas
Externí odkaz:
https://doaj.org/article/47cdd46fe09d4f619548677a08c6eb63
Autor:
Torben Steiniche, Sun Young Rha, Hyun Cheol Chung, Jeanette Baehr Georgsen, Morten Ladekarl, Marianne Nordsmark, Marie Louise Jespersen, Hyo Song Kim, Hyunki Kim, Carly Fein, Laura H. Tang, Ting Wu, Matthew J. Marton, Senaka Peter, David P. Kelsen, Geoffrey Ku
Publikováno v:
Cancer Medicine, Vol 10, Iss 23, Pp 8365-8376 (2021)
Abstract Purpose The ability of the T‐cell–inflamed gene expression profile (GEP) to predict clinical outcome in esophageal cancer (EC) is unknown. This retrospective observational study assessed the prognostic value of GEP and programmed death l
Externí odkaz:
https://doaj.org/article/2a9956843ede4de294156aa54a3bb155
Autor:
Ji Soo Park, Eun‐Ah Choe, Sejung Park, Chung Mo Nam, Woo Jin Hyung, Sung Hoon Noh, Seoyoung Lee, Hyo Song Kim, Minkyu Jung, Hyun Cheol Chung, Sun Young Rha
Publikováno v:
Cancer Medicine, Vol 10, Iss 10, Pp 3249-3260 (2021)
Abstract Background The effect of long‐term surveillance for asymptomatic patients after curative resection of gastric cancer is being debated. We compared the prognosis of Korean patients with recurrent gastric cancer according to the presence or
Externí odkaz:
https://doaj.org/article/8fac5304dd234334a8715066ccfec6d5
Autor:
Sun Young Rha1,2,3, Hyun Cheol Chung1,2 unchung8@yuhs.ac
Publikováno v:
Journal of Gastric Cancer. Jan2023, Vol. 23 Issue 1, p224-249. 26p.
Autor:
Do-Youn Oh, Jeeyun Lee, Keun-Wook Lee, Hyun Cheol Chung, Michael Chisamore, Paul Rhee, Taewan Kim, Sang Cheul Oh, Min Hee Ryu, Jun-Eul Hwang, Jaeyong Cho, Dae Young Zang, Byoung Yong Shim, William Ho, Ji Yeong Won, Eunhye Baek, SeungJae Baek
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/d5ffff58305f4f94bc17f16112e2a373
Autor:
Hyun Cheol Chung, Hendrik-Tobias Arkenau, Jeeyun Lee, Sun Young Rha, Do-Youn Oh, Lucjan Wyrwicz, Yoon-Koo Kang, Keun-Wook Lee, Jeffrey R. Infante, Sung Sook Lee, Margaret Kemeny, Ulrich Keilholz, Bohuslav Melichar, Alain Mita, Ruth Plummer, Denis Smith, Arnold B. Gelb, Huiling Xiong, Janet Hong, Vikram Chand, Howard Safran
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-10 (2019)
Abstract Background We evaluated the antitumor activity and safety of avelumab, a human anti–PD-L1 IgG1 antibody, as first-line switch-maintenance (1 L-mn) or second-line (2 L) treatment in patients with advanced gastric/gastroesophageal cancer (GC
Externí odkaz:
https://doaj.org/article/22a26bd6feb14e4185d7a995dfe688b6